Walleye Trading
DFTX icon

Walleye Trading’s Definium Therapeutics DFTX Stock Holding History

Walleye Trading’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$122K Sell
2,600
-500
-16% -$12.4K ﹤0.01% 3336
2026
Q1 		$58.6K Sell
3,100
-3,000
-49% -$50.9K ﹤0.01% 3641
2025
Q4 		$81.7K Buy
6,100
+1,000
+20% +$12.4K ﹤0.01% 3810
2025
Q3 		$60.1K Buy
+5,100
New +$47.6K ﹤0.01% 3907
2025
Q2 		– Sell
-100
Closed -$585 – 4540
2025
Q1 		$585 Buy
+100
New +$716 ﹤0.01% 3958

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Walleye Trading's DFTX Position: Q2 2026 in Review

Walleye Trading increased its Definium Therapeutics (DFTX) stake by 241% in Q2 2026, buying an estimated $322K and bringing the position to 18,450 shares worth $868K. The position accounts for ﹤0.01% of the portfolio, ranked #2376.

Walleye Trading first reported a position in DFTX in Q1 2025 and has held it in 5 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Walleye Trading held 18,450 shares of Definium Therapeutics worth $868K as of Q2 2026.
  • Walleye Trading bought 13,036 Definium Therapeutics shares in Q2 2026, an estimated $322K.
  • Definium Therapeutics made up ﹤0.01% of Walleye Trading's portfolio in Q2 2026, its #2376 holding.
  • Walleye Trading first reported a position in Definium Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.